3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasm Metastasis
2
Breast Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Interventions
Fulvestrant
2
ribociclib
1
duvelisib
1
Secretin
1
Rituximab
1
NVP-BKM120
1
Letrozole
1
Everolimus
1
CA-19-9 Antigen
1
Aspirin
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Hereditary Sensory and Autonomic Neuropathies
×
NVP-BKM120
×
Clear all
NCT01633060
2019-01-30
BELLE-3
Novartis
Phase 3
Terminated
432 enrolled
20 charts